Demyelination increases radial diffusivity in corpus callosum of mouse brain

Myelin damage, as seen in multiple sclerosis (MS) and other demyelinating diseases, impairs axonal conduction and can also be associated with axonal degeneration. Accurate assessments of these conditions may be highly beneficial in evaluating and selecting therapeutic strategies for patient management. Recently, an analytical approach examining diffusion tensor imaging (DTI) derived parameters has been proposed to assess the extent of axonal damage, demyelination, or both. The current study uses the well-characterized cuprizone model of experimental demyelination and remyelination of corpus callosum in mouse brain to evaluate the ability of DTI parameters to detect the progression of myelin degeneration and regeneration. Our results demonstrate that the extent of increased radial diffusivity reflects the severity of demyelination in corpus callosum of mouse brain affected by cuprizone treatment. Subsequently, radial diffusivity decreases with the progression of remyelination. Furthermore, radial diffusivity changes were specific to the time course of changes in myelin integrity as distinct from axonal injury, which was detected by betaAPP immunostaining and shown to be most extensive prior to demyelination. Radial diffusivity offers a specific assessment of demyelination and remyelination, as distinct from acute axonal damage.

[1]  Antonio Federico,et al.  Diffuse axonal and tissue injury in patients with multiple sclerosis with low cerebral lesion load and no disability. , 2002, Archives of neurology.

[2]  Sheng-Kwei Song,et al.  Relative indices of water diffusion anisotropy are equivalent in live and formalin‐fixed mouse brains , 2003, Magnetic resonance in medicine.

[3]  Manabu Onuki,et al.  Axonal degeneration is an early pathological feature in autoimmune‐mediated demyelination in mice , 2001, Microscopy research and technique.

[4]  P. Morell,et al.  Gene Expression in Brain during Cuprizone-Induced Demyelination and Remyelination , 1998, Molecular and Cellular Neuroscience.

[5]  Shu-Wei Sun,et al.  Diffusion tensor imaging detects and differentiates axon and myelin degeneration in mouse optic nerve after retinal ischemia , 2003, NeuroImage.

[6]  G. Barker,et al.  Diffusion tensor imaging of lesions and normal-appearing white matter in multiple sclerosis , 1999, Neurology.

[7]  Wolfgang Brück,et al.  Acute axonal damage in multiple sclerosis is most extensive in early disease stages and decreases over time. , 2002, Brain : a journal of neurology.

[8]  M A Horsfield,et al.  Diffusion magnetic resonance imaging in multiple sclerosis. , 1998, Journal of neurology, neurosurgery, and psychiatry.

[9]  John Russell,et al.  Dysmyelination Revealed through MRI as Increased Radial (but Unchanged Axial) Diffusion of Water , 2002, NeuroImage.

[10]  W. Brück,et al.  Acute axonal injury in multiple sclerosis. Correlation with demyelination and inflammation. , 2000, Brain : a journal of neurology.

[11]  R. Rudick,et al.  Axonal transection in the lesions of multiple sclerosis. , 1998, The New England journal of medicine.

[12]  P M Matthews,et al.  Evidence of axonal damage in the early stages of multiple sclerosis and its relevance to disability. , 2001, Archives of neurology.

[13]  P. Basser,et al.  A simplified method to measure the diffusion tensor from seven MR images , 1998, Magnetic resonance in medicine.

[14]  R. Ito,et al.  Diffusion tensor brain MR imaging in X-linked cerebral adrenoleukodystrophy , 2001, Neurology.

[15]  L K Weaver,et al.  White matter hyperintensities and neuropsychological outcome following carbon monoxide poisoning , 2002, Neurology.

[16]  P. Basser,et al.  Toward a quantitative assessment of diffusion anisotropy , 1996, Magnetic resonance in medicine.

[17]  V. Haughton,et al.  Diffusion tensor MR imaging in diffuse axonal injury. , 2002, AJNR. American journal of neuroradiology.

[18]  V. Perry,et al.  Axon damage and repair in multiple sclerosis. , 1999, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.

[19]  P. Morell,et al.  The Neurotoxicant, Cuprizone, as a Model to Study Demyelination and Remyelination in the Central Nervous System , 2001, Brain pathology.

[20]  B Bacci,et al.  Amyloid precursor protein and ubiquitin immunoreactivity in dystrophic axons is not unique to Alzheimer's disease. , 1991, The American journal of pathology.

[21]  W. Cammer,et al.  Atypical glial cells in demyelinated and hypomyelinated mouse brains , 1999, Brain Research.

[22]  Moses Rodriguez,et al.  Quantitation of spinal cord demyelination, remyelination, atrophy, and axonal loss in a model of progressive neurologic injury , 1999, Journal of neuroscience research.

[23]  M Cercignani,et al.  Diffusion tensor magnetic resonance imaging in multiple sclerosis , 2001, Neurology.

[24]  James R Stone,et al.  Antibodies to the C-terminus of the β-amyloid precursor protein (APP): a site specific marker for the detection of traumatic axonal injury , 2000, Brain Research.

[25]  B D Trapp,et al.  Axonal pathology in multiple sclerosis: relationship to neurologic disability. , 1999, Current opinion in neurology.

[26]  R. Armstrong,et al.  Absence of Fibroblast Growth Factor 2 Promotes Oligodendroglial Repopulation of Demyelinated White Matter , 2002, The Journal of Neuroscience.

[27]  P. Valk,et al.  Staging of multiple sclerosis (MS) lesions: pathology of the time frame of MS. , 2000 .

[28]  K. Suzuki,et al.  Microglial/macrophage accumulation during cuprizone-induced demyelination in C57BL/6 mice , 1998, Journal of Neuroimmunology.

[29]  Stephen G Waxman,et al.  Co-localization of sodium channel Nav1.6 and the sodium-calcium exchanger at sites of axonal injury in the spinal cord in EAE. , 2004, Brain : a journal of neurology.

[30]  J. Maldjian,et al.  Future applications of DWI in MS , 2001, Journal of Neurological Sciences.

[31]  F Barkhof,et al.  Axonal damage in the spinal cord of MS patients occurs largely independent of T2 MRI lesions , 2002, Neurology.

[32]  K Suzuki,et al.  Episodic demyelination and subsequent remyelination within the murine central nervous system: changes in axonal calibre , 2001, Neuropathology and applied neurobiology.

[33]  M S Buchsbaum,et al.  Regional and global changes in cerebral diffusion with normal aging. , 2001, AJNR. American journal of neuroradiology.

[34]  Ueli Suter,et al.  Quantifying the Early Stages of Remyelination Following Cuprizone‐induced Demyelination , 2003, Brain pathology.

[35]  V. Perry,et al.  Axonal damage in acute multiple sclerosis lesions. , 1997, Brain : a journal of neurology.